Products

Workflow Box
Mirada Medical
Oncology AI
Mirada Medical's Workflow Box is an AI-powered automation platform that streamlines cancer treatment planning and radiation oncology workflows through advanced autocontouring and intelligent data routing.

See all 1 product →

About Mirada Medical

Mirada Medical develops advanced AI-powered medical imaging software designed to enhance the precision and personalization of cancer treatment. Their innovative solutions aim to improve accessibility and efficiency in diagnostic imaging workflows for healthcare providers globally. The company’s core product offerings include Mirada XD™ for comprehensive diagnostic imaging, RTx for radiation oncology, and Simplicit90Y™ for interventional radiology and dosimetry. These platforms leverage AI-assisted workflows to streamline technically complex image processing tasks, such as PET/CT reporting and autocontouring for radiation therapy, ultimately striving to improve patient outcomes by making cancer care more accessible and accurate.

The company’s technology is utilized across various specialties, including diagnostic radiology, molecular imaging, radiation oncology, and medical oncology. Mirada Medical focuses on providing tools that enable clinicians to confidently diagnose disease, assess treatment response, and plan radiation therapy or surgical interventions. With a strategic expansion into theranostics, Mirada continues to innovate by integrating seamlessly into existing clinical diagnostics and therapeutic workflows, empowering healthcare professionals with cutting-edge technology for improved diagnostic accuracy and patient care.

What Physicians Need to Know

Specialization
Mirada Medical specializes in advanced medical imaging software and AI tools primarily for cancer care. Their solutions span diagnostic radiology, molecular imaging, radiation oncology, medical oncology, and interventional procedures, focusing on simplifying complex image processing tasks.
Key Products
Their product portfolio includes DLCExpertu2122 for AI-powered autocontouring in radiation oncology, Workflow Boxu2122 for Zero-Clicku2122 automation, Mirada XDu2122 for diagnostic imaging (PET/CT, PET/MR, nuclear medicine, image fusion), RTxu2122 for image registration and visualization in radiotherapy, and Simplicit90Yu2122 for dosimetry planning in Y-90 SIRT.
Key Differentiators
Mirada Medical is notable for developing DLCExpertu2122, the world's first FDA-cleared AI software for contouring in radiation oncology. Their Deep Learning (AI) technology generates contours often indistinguishable from human-drawn ones, and their Zero-Clicku2122 automation platform streamlines complex workflows. They offer vendor-neutral software that integrates with various systems and have a strong focus on precision medicine and personalized cancer care.
Technology Stack
The core of their technology stack involves Deep Learning and neural networks for AI-powered autocontouring and automation. They utilize advanced, industry-leading deformable image registration algorithms for multi-modal fusion and adaptive re-planning. Their solutions are designed for flexible deployment and can be integrated into cloud-native platforms through partnerships.
Physician Tip

For physicians, Mirada Medical's tools offer significant time savings, with DLCExpertu2122 potentially reducing contouring time by up to 75%, thereby accelerating patient treatment pathways. The AI-generated contours provide unprecedented consistency and accuracy, often matching or exceeding human-drawn contours, which enhances confidence in diagnosis, treatment assessment, and planning. The automation reduces manual effort in complex tasks, allowing clinicians to focus on more critical aspects of patient care. Furthermore, the software's flexibility allows for customization to specific hospital protocols and seamless integration with existing PACS and Treatment Planning Systems (TPS). Recent advancements also include AI-assisted PSMA PET/CT solutions aimed at improving prostate cancer diagnosis and treatment stratification.

Mirada Medical's products are designed for seamless integration with existing hospital infrastructure, including Picture Archiving and Communication Systems (PACS) and Treatment Planning Systems (TPS). They also operate on an OEM basis, partnering with leading healthcare companies such as GE, Boston Scientific, Canon, Philips, Varian, and Change Healthcare to embed their advanced technologies. Notably, their solutions are integrated into platforms like RamSoft's OmegaAIu00ae, providing cloud-native access to their tools.

Products by Mirada Medical

1 product in the directory

Workflow Box
Mirada Medical
Oncology AI
Mirada Medical's Workflow Box is an AI-powered automation platform that streamlines cancer treatment planning and radiation oncology workflows through advanced autocontouring and intelligent data routing.

What the Web Says

Mirada Medical is a global brand in medical imaging software, primarily focused on cancer diagnosis and treatment. Their flagship product, DLCExpert, is an AI-powered autocontouring solution for radiation oncology that has received FDA 510(k) clearance in the USA and CE Marking in Europe. The software aims to automate the time-consuming task of contouring for treatment planning, bringing quality and consistency to the process. Employer reviews for Mirada Medical are limited but generally positive, with employees highlighting a good work-life balance, pay and benefits, and a positive culture.

Overall: Positive

Strengths

  • DLCExpert provides consistent and accurate OAR contouring, saving time for clinicians.
  • Contours generated by DLCExpert are often indistinguishable from those drawn by clinical experts.
  • Mirada Medical products offer flexible and configurable solutions that can integrate with existing PACs and load images from various scanners.
  • The company has a strong focus on customer success, offering ongoing support and optimization.
  • Employees report a good work-life balance and positive company culture.
  • Competitive pay and benefits for employees.

Limitations

  • Limited number of employee reviews available, making it difficult to form a comprehensive opinion on employer satisfaction.
  • No recent product reviews from major IT review sites like G2, Capterra, or Reddit were found, making it difficult to assess current user sentiment for their products.
  • Some general medical practice management software alternatives on G2 and Capterra have higher star ratings, though these are not direct comparisons to Mirada Medical's specialized products.

Based on reviews from: Indeed.com, Mirada Medical (mirada-medical.com), Imaging Technology News, AuntMinnie, The Oxford Trust, G2, Capterra

Last updated: 2026-07-19

Videos

News, demos, and interviews about Mirada Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for Mirada Medical →

View all on YouTube

Press & Coverage

Mirada Medical
Mirada Medical and clinical partners secure u00a3500,000 grant to transform prostate cancer treatment with AI and enhanced reporting.
Mirada Medical received a u00a3500,000 grant from Innovate UK's Advancing Precision Medicine program to develop an AI-assisted PSMA PET/CT solution for improved prostate cancer diagnosis. This funding aims to support the widespread adoption of PSMA PET/CT in clinics, addressing challenges related to large imaging volumes, staffing, and clinical workflows.
2024-06
Mirada Medical
Mirada Medical Announces Key Leadership Appointments: Karen Fitchett Announced as CEO and Joe Noto Joins as VP of Revenue.
Mirada Medical expanded its executive leadership team with Karen Fitchett stepping into the CEO role and Joe Noto joining as VP of Revenue, reinforcing the company's focus on growth and market expansion in diagnostics, therapeutics, and theranostics.
unknown
Mirada Medical
Mirada Medical Partners with RamSoft to Expand Globally
Mirada Medical partnered with RamSoft to integrate its advanced cancer care technology into RamSoft's OmegaAIu00ae, aiming to enhance global patient diagnosis and treatment by expanding access to Mirada's pioneering technology.
2023-06
Mirada Medical
Apposite Capital Makes Further Investment in Mirada Medical to Advance Precision Cancer Care
Apposite Capital made a further investment in Mirada Medical, bringing the total investment since 2019 to approximately $20 million of new growth capital to advance precision imaging software and image-guided tools for cancer care.
2023-05
Mirada Medical
Mirada Medical showcases DLCExpertu2122, the first FDA-cleared Artificial Intelligence (AI) software for Contouring in Radiation Oncology, at ASTRO 2018
Mirada Medical showcased DLCExpertu2122, the world's first FDA-cleared AI-powered autocontouring solution for radiation oncology, at ASTRO 2018, which automates the time-consuming task of contouring for treatment planning and is already in use in multiple academic medical centers worldwide.
2018-10
Imaging Technology News
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI | Imaging Technology News
Mirada Medical joined a UK artificial intelligence (AI) consortium that received u00a350 million in government funding to expedite the development and adoption of AI in healthcare and the NHS.
2018-12
American Society for Radiation Oncology (ASTRO)
Mirada Medical receives FDA 510(k) clearance for the worldu2019s first Artificial Intelligence (AI) software, DLCExpertu2122, for au - American Society for Radiation Oncology (ASTRO)
Mirada Medical received FDA 510(k) clearance for its Deep Learning Contouring (DLC) software, DLCExpert, for clinical use in the USA, making it the world's first AI software for contouring in radiation oncology.
2018-07
American Society for Radiation Oncology (ASTRO)
Mirada Medical Releases DLCExpert - First commercially available Artificial Intelligence (AI) autocontouring software for radiation oncology.
Mirada Medical released DLCExpertu2122, the first commercially available AI-based autocontouring software for radiation oncology, designed to automate and enhance the quality and consistency of contouring for treatment planning.
2018-02

Frequently Asked Questions

Mirada Medical provides AI-powered solutions primarily for cancer care, including DLCExpertu2122 for automated contouring in radiation oncology and Mirada XDu2122 for advanced diagnostic imaging, such as PET/CT, PET/MR, and SPECT/CT analysis, tumor tracking, and image fusion. They also offer Simplicit90Yu2122 for personalized dosimetry planning in interventional radiology, and their Workflow Boxu2122 2.0 platform enables Zero-Clicku2122 automation for various workflows.
Mirada Medical ensures compliance through regulatory clearances like FDA 510(k) (e.g., for DLCExpertu2122 and Mirada XDu2122) and CE Marking for the European market. They operate as both a Data Controller and Data Processor, adhering to Data Protection Legislation, and employ a Data Protection Officer to manage data privacy. Patient data is processed and stored primarily on encrypted cloud services such as Microsoft 365 (Azure), Salesforce, and AWS, with data centers located in the UK, EEA, or US, and they commit to collecting only necessary data and minimizing access.
Mirada Medical's revenue model is based on B2B transactions, primarily through software subscriptions and strategic partnerships. Clients typically engage through structured agreements that include licensing fees for products like Mirada XDu2122 and Simplicit90Yu2122, along with setup costs and recurring fees for support and updates. Specific pricing details are not publicly listed, and institutions are advised to contact Mirada Medical directly to obtain a detailed quote tailored to their requirements.
Mirada Medical offers comprehensive customer support through its dedicated Customer Success team, comprising world-class technicians and clinical experts. This support includes initial needs assessment, in-clinic deployment, clinical onboarding to configure solutions to specific clinical pathways, and ongoing optimization. They also facilitate community engagement programs for users to share best practices and insights.
Yes, Mirada Medical's products are designed to integrate seamlessly with existing PACS and RIS systems, and can load images from various scanners, offering flexible deployment options. They have established strategic partnerships with leading healthcare technology companies, including GE Healthcare, Boston Scientific, Canon, Philips, Varian, Change Healthcare, RamSoft, Optellum, and ConcertAI's TeraRecon, to expand access to their solutions globally.
Founded in 2000/2001, Mirada Medical is a UK-based company focused on advancing cancer care through innovative imaging software. They have secured significant investment, including approximately $20 million in new growth capital from Apposite Capital since 2019, which is intended to support product expansion and enhance solutions for physicians. Their long-term vision is to accelerate cancer care by delivering personalized, image-guided treatments, driven by continuous research and development and collaboration with academic institutions.

Related Companies

Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide […]

TSI (Transworld Systems Inc.) is a long-standing company primarily known for its debt collection and business process outsourcing services. While they serve various industries, including healthcare, their core offering is focused on accounts receivable management and collections rather than healthcare-specific AI development. They provide solutions to help healthcare providers manage patient accounts, improve cash flow, […]

TrialX is a healthcare AI company specializing in clinical research and space health informatics. The company develops platforms designed to connect patients with clinical trials and facilitate research data collection. Their offerings include an enterprise patient recruitment platform (iConnect) that provides a clinical trials finder (Dory), study website builders, pre-screeners, referral tracking, and volunteer registries. […]

Thinkitive is a global IT services and solutions company that specializes in digital transformation, enterprise application services, outsourced product development, and a testing center of excellence. For physicians, Thinkitive offers a range of AI-driven healthcare solutions designed to streamline clinical and administrative workflows, enhance patient care, and improve operational efficiency. Their services include custom healthcare […]

Taction Software is a U.S.-based healthcare IT and custom software development company specializing in HIPAA-compliant solutions. They build AI-powered applications for healthcare, ranging from rapid clinical AI prototypes to production-grade systems with EHR integration, ambient documentation, and predictive analytics. The company focuses on transforming healthcare delivery through secure, compliant, and innovative software solutions that aim […]

SUPERWISE offers an enterprise AI governance and operations platform designed to help organizations, including those in healthcare, deploy and manage autonomous AI systems with oversight and control. The platform addresses governance, compliance, and operational challenges associated with AI and machine learning deployments. It features real-time guardrails for AI systems, model observability capabilities, and compliance automation, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.